CELL AND TISSUE SYSTEMS, INC.

Basic Information

2231 Technical Parkway, Suite A
NORTH CHARLESTON, SC, 29406-4931

Company Profile

n/a

Additional Details

Field Value
DUNS: 175100333
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Lessons from Nature: Antifreeze Glycolipids for Cryopreservation of Mammalian Cel

    Amount: $224,002.00

    DESCRIPTION (provided by applicant): Storage of cells for many researchers simply involves addition of 10% DMSO or similar cryoprotectants to cells in suspension, putting them in cryovials and slow co ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Cartilage storage solution for chondrocyte viability and biomaterial preservation

    Amount: $312,642.00

    DESCRIPTION (provided by applicant): Resurfacing of articular cartilage with cold stored osteochondral allografts is employed clinically for repair of trauma and osteoarthritis-induced articular carti ...

    SBIR Phase I 2013 Department of Health and Human Services
  3. hiPS Derived Cardiomyocyte Assay for Screening Toxicant Differentiation Effects

    Amount: $224,925.00

    ABSTRACT Obesity is a major global health issue. According to a recent report in the Journal of the American Medical Association non-Hispanic blacks have the highest age-adjusted rates of obesity (49. ...

    SBIR Phase I 2013 Department of Health and Human Services
  4. Non-Enzymatic Cryogenic Isolation of Therapeutic Cells

    Amount: $268,561.00

    DESCRIPTION (provided by applicant): In modern day medicine, cellular therapies, regenerative medicine and tissue engineering all involve technologies for harvesting, expanding, modifying and re-impla ...

    SBIR Phase I 2012 Department of Health and Human Services
  5. Feasibility of immunotherapy by ice-free cryopreservation of engineered human all

    Amount: $262,005.00

    DESCRIPTION (provided by applicant): Autologous regenerative medicine tissue therapy costs are very high because when individual tissues are manufactured all the costs fall on a single patient. Alloge ...

    SBIR Phase I 2012 Department of Health and Human Services
  6. Feasibibility of deep hypothermic (18-22C) perfusion storage of livers for transp

    Amount: $185,898.00

    DESCRIPTION (provided by applicant): More than 43,000 Americans die each year from liver disease, making it the 10th leading disease- related cause of death in the US. Cirrhosis with irreversible inju ...

    SBIR Phase I 2011 Department of Health and Human Services
  7. Pancreas perfusion with PFC-Unisol

    Amount: $312,027.00

    DESCRIPTION (provided by applicant): There is a worldwide consensus that islet transplantation may be considered a viable option for the treatment of insulin-dependent diabetes mellitus, and clinical ...

    SBIR Phase I 2011 Department of Health and Human Services
  8. Perfusion Device for Lung Evaluation and Transplantation

    Amount: $224,811.00

    DESCRIPTION (provided by applicant): Twenty four million Americans are affected with end-stage lung disease which is the 4th leading cause of death in the US, and there are currently 2,122 candidates ...

    SBIR Phase I 2011 Department of Health and Human Services
  9. Design and Assessment of a Compliant Nanofibrous Vascular Graft

    Amount: $278,179.00

    DESCRIPTION (provided by applicant): Vascular grafting is performed clinically to repair or replace diseased coronary artery and peripheral vessels to restore normal blood flow patterns. Synthetic gra ...

    SBIR Phase I 2011 Department of Health and Human Services
  10. Assessment of MitoQ Therapy for Cold Preservation Renal Damage

    Amount: $189,552.00

    DESCRIPTION (provided by applicant): Renal transplantation has been a clinical reality for nearly 40 years. Transplantation is the only effective solution for organ end-stage renal failure. Long term ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government